PDF Cover

Phacoemulsification Sets Market

Phacoemulsification Sets Market

The market for Phacoemulsification Sets was estimated at $2.9 billion in 2024; it is anticipated to increase to $4.4 billion by 2030, with projections indicating growth to around $6.3 billion by 2035.

Report ID:DS1801406
Author:Debadatta Patel - Senior Consultant
Published Date:November 2025
Datatree
Life Science
Medical Device
Phacoemulsification Sets
Share
Report Summary
Table of Contents
Methodology
Market Data

Global Phacoemulsification Sets Market Outlook

Revenue, 2024

$2.9B

Forecast, 2034

$5.8B

CAGR, 2024 - 2034

7.4%
The Phacoemulsification Sets industry revenue is expected to be around $3.1 billion in 2025 and expected to showcase growth with 7.4% CAGR between 2025 and 2034. The significant growth in the Phacoemulsification Sets market can be attributed to key factors driving it forward efficiently. Chief of these factors is the increasing prevalence of cataracts and other eye related conditions among the elderly population. Moreover technological advancements have led to the creation of effective and less invasive Phacoemulsification Sets consequently increasing their acceptance in the healthcare industry. The continuous importance of these sets is further emphasized by their role in improving patient outcomes during eye surgeries establishing them as an essential tool, in contemporary eye care.

Specialized surgical tools known as Phacoemulsification Setsre utilized in the removal of cataracts by employing ultrasonic technology to fragment the cloudy lens into small pieces that are then removed from the eye through aspiration methods. These sets are highly praised for their accuracy and safety in addition to their effectiveness which has made them a top choice among ophthalmologists globally. Common areas where these sets find application include hospitals and eye clinics along, with surgical centers.

Phacoemulsification Sets market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034

Market Key Insights

  • The Phacoemulsification Sets market is projected to grow from $2.9 billion in 2024 to $5.8 billion in 2034. This represents a CAGR of 7.4%, reflecting rising demand across Cataract Surgery, Secondary Cataract Treatment and Pediatric Cataract Removal.

  • Alcon, Bausch & Lomb Incorporated, and Carl Zeiss Meditec AG are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Phacoemulsification Sets market and are expected to observe the growth CAGR of 4.8% to 7.1% between 2024 and 2030.
  • Emerging markets including Brazil, Indonesia and South Africa are expected to observe highest growth with CAGR ranging between 8.5% to 10.2%.

  • Transition like Technological Advancements is expected to add $400.0 million to the Phacoemulsification Sets market growth by 2030

  • The Phacoemulsification Sets market is set to add $3.0 billion between 2024 and 2034, with manufacturer targeting Glaucoma Surgery & Retinal Detachment Clinical Applications projected to gain a larger market share.
  • With

    rising prevalence of cataract diseases, and

    technological advancements in ophthalmic surgery, Phacoemulsification Sets market to expand 104% between 2024 and 2034.

phacoemulsification sets market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032

Opportunities in the Phacoemulsification Sets

Collaborations, between manufacturers and healthcare providers can greatly benefit the Phacoemulsification Sets market by enabling the sharing of knowledge and expertise to enhance product efficiency and effectiveness and reach markets that have not only yet been explored.

Growth Opportunities in North America and Asia-Pacific

North America Outlook

North America stands out as a market for Phacoemulsification Sets due to its well developed healthcare system and infrastructure that support medical advancements in the field of eye care treatment and surgeries like cataract removal procedure amid the growing elderly population affected by eye related ailments in the region. The competitive environment in North America is fueled by established manufacturers operating here and the widespread acceptance of state of the art instruments that drive innovation and quality in the industry. Important factors driving market growth comprise research endeavors aimed at enhancing medical technologies for better patient outcomes; governmental backing for cutting edge medical tools; and the increasing preference for less invasive surgical procedures, among patients seeking effective treatment options. The expensive nature of Phacoemulsification Sets might hinder the markets expansion in this region.

Asia-Pacific Outlook

The potential for the Phacoemulsification Sets market in the Asia Pacific region is significant and prominent in countries like China, India and Japan. Factors such as urbanization, growing awareness of eye health and an increase in disposable income contribute to the expansion of the market in this region. Local manufacturers entering the market with cost Phacoemulsification Sets are intensifying competition. One of the driving factors for the market in this region is the increasing number of cataract surgeries due, to a large and aging population. However the growth of the market may be impeded by a shortage of eye doctors and insufficient healthcare facilities, in certain regions.

Market Dynamics and Supply Chain

01

Driver: Rising Prevalence of Cataract Diseases

The rise in cases of cataract worldwide presents a market opportunity for Phacoemulsification Sets. Given that cataract remains a cause of blindness on a global scale the demand for effective and less invasive surgical options like Phacoemulsification Sets is also increasing. These sets consist of tools and equipment designed to help break down and remove the cataract affected lens resulting in better vision and enhanced quality of life for patients. The expanding elderly population who are also more prone, to cataract conditions further also drives the market growth for sets.


The ongoing progress in surgical technologies is also driving the expansion of the Phacoemulsification Sets market Forward strides like improved fluid control mechanisms and power adjustments as well as refined handpiece structures in Phacoemulsification Sets guarantee safer and more effective cataract procedures These technological upgrades not only better surgical results but also lessen recovery time after surgery making Phacoemulsification Sets a popular option, among eye specialists.

02

Restraint: High Cost of Phacoemulsification Sets

The expensive nature of Phacoemulsification Sets poses a challenge, in the market sector. Consequently these sets contain technology and precise tools that are often priced above the budget of numerous healthcare facilities especially in developing regions. This steep pricing directly affects market demand as purchasers may choose more affordable albeit less effective alternatives.

03

Opportunity: Technological Innovations and Evolving Consumer Needs

Recent advancements in technology have brought about exciting new possibilities for Phacoemulsification Sets in the healthcare industry. Breakthroughs like incision cataract surgery and femtosecond laser assisted cataract surgery have significantly improved the efficiency of phacoemulsification procedures leading to a rise in the popularity of these sets, among healthcare providers and patients alike. Companies that prioritize research and development to enhance the quality of their products stand to achieve an advantage in the industry.


As the worlds population gets older gradually with time passing by each year the likelihood of cataracts and various other eye related issues is anticipated to increase. This creates an opportunity in the market for Phacoemulsification Sets particularly since these sets play a crucial role, in cataract surgery. Companies that can meet the increasing need by offering notch dependable sets may anticipate experiencing significant expansion in the upcoming years.

04

Challenge: Lack of Skilled Professionals

The Phacoemulsification procedure requires highly skilled professionals for its execution. There is a scarcity of such trained professionals, particularly in underdeveloped and developing countries. This lack of skilled professionals can hinder the adoption of Phacoemulsification Sets, thus impeding market growth.

Supply Chain Landscape

1
Raw Material Suppliers

BASF

DowDuPont

2
Component Manufacturers

Johnson & Johnson

Bausch & Lomb

3
Assembly & Packaging

Alcon

Abbott Medical Optics

4
Distributors & End Users

Medline

Henry Schein

*The illustration highlights the key stakeholders within the supply chain ecosystem.

Applications of Phacoemulsification Sets in Cataract Surgery, Secondary Cataract Treatment & Pediatric Cataract Removal

Cataract Surgery

Phacoemulsification sets are extensively used in cataract surgeries. These sets typically include a phacoemulsification handpiece, irrigation and aspiration tubing, and a variety of microsurgical instruments. The handpiece emits ultrasonic vibrations that break up the cloudy lens, which is then aspirated out. This method offers a unique advantage of small incision size, leading to faster recovery. Top players in this application include Alcon and Bausch & Lomb, known for their innovative and efficient phacoemulsification sets.

Secondary Cataract Treatment

Phacoemulsification sets are also employed in the treatment of secondary cataracts, posterior capsule opacification. In this application, a specific of phacoemulsification set, equipped with a Nd

Pediatric Cataract Removal

Pediatric cataract removal is another significant application of phacoemulsification sets. Specialized sets with smaller instruments are used for this delicate procedure. The process involves the emulsification of the lens material, followed by aspiration, ensuring minimal trauma to the childs eye.

Recent Developments

December 2024

Johnson & Johnson Vision introduced an advanced Phacoemulsification Set with AI capabilities, enhancing precision and safety during cataract surgeries

October 2024

Alcon launched a next-generation Phacoemulsification Set with a high-frequency oscillation feature to improve surgical outcomes

August 2024

Bausch & Lomb announced a significant upgrade to their Phacoemulsification Sets, incorporating a new fluidics system for smoother operation.

Phacoemulsification sets have been gaining significant attention in the ophthalmic industry due to their role in modern cataract surgery. Recent market developments indicate a growing demand for these specialized surgical tools, driven by an aging global population and a rise in eye-related disorders.

Impact of Industry Transitions on the Phacoemulsification Sets Market

As a core segment of the Medical Device industry, the Phacoemulsification Sets market develops in line with broader industry shifts. Over recent years, transitions such as Technological Advancements and Rise in Age-related Eye Disorders have redefined priorities across the Medical Device sector, influencing how the Phacoemulsification Sets market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Technological Advancements

In years the phacoemulsification sets sector has seen notable technological progressions advancements occur significantly advance significantly over time advanced greatly. One key example is the emergence of incision cataract surgery which has transformed this area of expertise field providing patients with improved comfort levels comfort quicker recovery times recovery and lower chances of complications risk of complications. This shift has not only just boosted the efficiency of phacoemulsification sets. has also enriched the overall experience for patients, in general. The impact of this shift can be observed in sectors like the medical equipment manufacturing field; for instance in the increased need for modern phacoemulsification kits which has sparked a rise, in research and development efforts.

This industry transition is expected to add $400 million in the industry revenue between 2024 and 2030.
02

Rise in Age-related Eye Disorders

The increasing prevalence of age-related eye disorders such as cataracts has led to a surge in the demand for phacoemulsification sets. This transition has had a profound impact on the healthcare industry, prompting hospitals and clinics to upgrade their ophthalmology departments with the latest phacoemulsification technologies.

Related Reports

Loading related reports...